Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions
| Autor: | Smita Kayal, Kadambari Dharanipragada, Sunu Lazar Cyriac, Unni S Pillai, Dhanraju Krishnappa Muniswamy, Dhanapathi Halanaik, Navin Kumar, Yadav Nisha, Biswajit Dubashi, Ponraj Madasamy, Sadishkumar Kamalanathan |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
0301 basic medicine medicine.medical_specialty Nausea Breast Cancer Lymphedema Psychological intervention Breast Neoplasms Disease 03 medical and health sciences breast cancer 0302 clinical medicine Breast cancer Cancer Survivors Quality of life Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Prospective Studies Mastectomy Aged Bone mineral Radiotherapy business.industry Late effects General Medicine Middle Aged medicine.disease Combined Modality Therapy Survival Rate Treatment Outcome 030104 developmental biology quality of life 030220 oncology & carcinogenesis Vomiting Female medicine.symptom Cognition Disorders Breast carcinoma business Research Article Follow-Up Studies |
| Zdroj: | Asian Pacific Journal of Cancer Prevention : APJCP |
| ISSN: | 2476-762X |
| DOI: | 10.31557/apjcp.2019.20.9.2673 |
| Popis: | Purpose: To study the late toxicities of treatment and its impact on Breast cancer survivors among Indian patients. Materials and Methods: Our study recruited 152 curatively treated non metastatic carcinoma breast patients. The baseline demographic details, disease related and treatment related information were collected. The late effects included breast cancer related lymphedema, shoulder dysfunction, treatment induced bone loss, hypothyroidism, cardiac dysfunction, and chemotherapy induced cognitive dysfunction and Quality of life. Results: The median age was 47 years (range 27 -72 years). The cumulative frequency of BCRL and shoulder dysfunction was 31.57% and 34.86% respectively. The improvement in BCRL with corrective intervention was not statistically significant. The BCRL was significantly associated with shoulder dysfunction. The frequency of loss of bone mineral density was 38.15%. There was statistically significant improvement in bone mineral density with interventions. The cumulative rate of hypothyroidism and cardiac dysfunction was 14.47 % and 2.17% respectively which improved after corrective therapy. We did not find any delayed cognitive dysfunction. There was improvement in global health, physical function, role function, fatigue, Nausea, vomiting, pain scores, insomnia, Loss of appetite, diarrhea and arm symptoms over time with intervention. Conclusion: Our study has shown that nearly half of the survivors were suffering from at least one of the late effects. The intervention helped in improving the loss of bone mineral density, hypothyroidism, cardiac dysfunction and quality of life in Breast cancer survivors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|